Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of...
Background Immune checkpoint inhibitors have transformed melanoma therapy but frequently cause immune-related adverse events (irAEs), including colitis, that limit treatment. Reliable biomarkers...
jitc.bmj.com